Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,929 GBX | -0.31% | +6.21% | +7.99% |
04-26 | HIKMA PHARMACEUTICALS : Hikma’s Q1 progress appreciated by the markets | |
04-25 | Hikma Pharmaceuticals plc Approves Final Dividend, Payable on 3 May 2024 | CI |
ETFs positioned on Hikma Pharmaceuticals PLC
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.44% | 1,120 M€ | +0.53% | ||
0.25% | 3 M€ | +9.95% | - | |
0.20% | 11 M€ | +0.83% | - | |
0.16% | 18 M€ | +3.01% | - | |
0.15% | 5 M€ | +10.09% | - | |
0.15% | 14 M€ | +5.66% | - | |
0.04% | 6 M€ | -.--% | ||
0.02% | 10 M€ | -3.35% | - | |
0.01% | 31 M€ | +2.76% | - | |
0.01% | 284 M€ | -.--% | ||
0.01% | 206 M€ | -.--% | ||
0.01% | 1,166 M€ | +0.26% | - | |
0.01% | 607 M€ | +0.05% | - | |
0.01% | 23 M€ | -.--% | - | |
0.01% | 786 M€ | -.--% | ||
0.01% | 273 M€ | +14.71% | ||
0.00% | 389 M€ | +6.29% | - | |
0.00% | 34 M€ | +1.32% | - | |
0.00% | 7 M€ | +0.11% | - | |
0.00% | 34 M€ | +6.29% | - | |
0.00% | 237 M€ | +0.14% | - | |
0.00% | 302 M€ | +3.99% | - | |
0.00% | 39 M€ | +4.22% | - | |
0.00% | 26 M€ | -4.26% | - |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+7.99% | 5.36B | |
+31.84% | 699B | |
+26.49% | 571B | |
-3.92% | 364B | |
+18.76% | 326B | |
+2.82% | 286B | |
+14.47% | 236B | |
+4.67% | 198B | |
-12.19% | 194B | |
-3.37% | 154B |
- Stock Market
- Equities
- HIK Stock
- Funds and ETFs Hikma Pharmaceuticals PLC